TECHNOLOGY/PRODUCTS

Two patented technology platforms with numerous applications

Wound Healing Technology: Altrazeal®

Altrazeal® is a new class of material designed to optimize the wound bed environment and accelerate healing. Produced as a sterile powder, Altrazeal® is unique in application and performance on a moist wound surface. When applied to a moist wound, the powder interacts with wound exudate and hydrates. Hydration with exudate causes the poweder to aggregate irreversibly and form a moist wound dressing which conforms to the surface of a wound bed and seals the wound.

Transmucosal Drug Delivery: OraDisc

A novel, patented, cost-effective, commercially-viable, water-erodible pharmaceutical carrier device, the multi-layered device may be applied to mucosal surfaces, and adheres immediately, delivering actives to treat specific localized diseases/disorders. OraDisc technology can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device causes minimum discomfort, is easy to apply and capable of providing tailored erosion rates to deliver therapeutics over different time intervals.

Contact Us

Contact Us

TECHNOLOGY/PRODUCTS

Two patented technology platforms with numerous applications

Wound Healing Technology: Altrazeal®

Altrazeal® is a new class of material designed to optimize the wound bed environment and accelerate healing. Produced as a sterile powder, Altrazeal® is unique in application and performance on a moist wound surface. When applied to a moist wound, the powder interacts with wound exudate and hydrates. Hydration with exudate causes the poweder to aggregate irreversibly and form a moist wound dressing which conforms to the surface of a wound bed and seals the wound.

Transmucosal Drug Delivery: OraDisc

A novel, patented, cost-effective, commercially-viable, water-erodible pharmaceutical carrier device, the multi-layered device may be applied to mucosal surfaces, and adheres immediately, delivering actives to treat specific localized diseases/disorders. OraDisc technology can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device causes minimum discomfort, is easy to apply and capable of providing tailored erosion rates to deliver therapeutics over different time intervals.

Natalia Kirsten

MD

Global Research Advisor

LEADERSHIP:

– Senior Physician, Institute for Services in Health Care Research in Dermatology and Nursing

– Former Resident, Department of Dermatology, Professor Carle Paul Larrey Hospital University of Toulouse, France

EDUCATION:

– University of Hamburg

Natalia Kirsten

mD

Global Research Advisor

LEADERSHIP:

– Senior Physician, Institute for Services in Health Care Research in Dermatology and Nursing

– Former Resident, Department of Dermatology, Professor Carle Paul Larrey Hospital University of Toulouse, France

EDUCATION:

– University of Hamburg

Lawrence A. Lavery

dPM, MPH

Professor, Plastic Surgery, UT Southwestern Medical Center

LEADERSHIP:

– Medical Director, Diabetic Limb Salvage Program, Parkland Hospital

– Member, International Working Group on the Diabetic Foot

– Past chair of the American Diabetes Association Foot Care Counsel and the American Public Health Association’s Foot Section

EDUCATION:

– University of Texas Health Science Center, Dr. William Scholl College of Podiatric Medicine, Indiana University

Lawrence A. Lavery

dPM, MPH

Professor, Plastic Surgery, UT Southwestern Medical Center

LEADERSHIP:

– Medical Director, Diabetic Limb Salvage Program, Parkland Hospital

– Member, International Working Group on the Diabetic Foot

– Past chair of the American Diabetes Association Foot Care Counsel and the American Public Health Association’s Foot Section

EDUCATION:

– University of Texas Health Science Center, Dr. William Scholl College of Podiatric Medicine, Indiana University